The latter carcinomas had significantly higher ERBB2 expression levels than all the other groups (p < 0.0001 for the difference with the 0+, 1+, and 2+ NA carcinomas; p = 0.0017 for DE and p = 0.0022 for 2+ WA carcinomas). The gene discussed is ERBB2; the disease is carcinoma.